Isoflavones found in soy products can help reduce the risk of developing early prostate cancer in men who have consumed soy their entire lives but might also increase the risk of advanced prostate cancer.
A U.S. study found that brachytherapy, a minimally invasive procedure that involves the implantation of radioactive seeds in the prostate, appeared to be as effective in men 60 and younger as in older men in treating localized prostate cancer. "Every man with prostate cancer, regardless of his age, should have access to the treatment that is best for his cancer and lifestyle," a researcher said.
Contrary to previously held beliefs, the antioxidants in tomatoes may provide no defense against the risk of developing prostate cancer, a new study found. Currently, the FDA allows makers of tomato-based products to claim that tomatoes reduce the risk of prostate, gastric, ovarian and pancreatic cancer.
Japanese researchers report patients who took high doses of fish oil along with statins had fewer heart problems than those who took drugs alone. A long-term intake of fish oil plus statins helped reduce the death risk for high-cholesterol subjects by 19% compared with patients on drugs alone, the study showed.
A study of nearly 70,000 men between 1982 and 1992 found that losing weight can reduce the risk of aggressive prostate cancer. Men in the study who lost more than 11 pounds had a lower risk for the disease than those whose weight remained the same over a decade.
Men in their 40s and 50s who test above the median on their PSA test are at significantly increased risk of developing prostate cancer and may benefit from earlier prostate cancer screening, according to a report in the September issue of Urology. Currently, the American Cancer Society and the American Urological Association recommend that men should be screened for prostate cancer at age 50. Results of the study, which indicate men may develop the disease in early middle-age, suggest that ages for prostate cancer screening should be lowered.